Business Description
BeBetter Med Inc
ISIN : CNE100007CZ3
Share Class Description:
SHSE:688759: Ordinary Shares - Class ATotal Employee Number:
160Compare
Compare
Traded in other countries / regions
688759.China IPO Date
2025-10-28Description
BeBetter Med Inc is a biopharmaceutical company based in China, focusing on independent research and development of drugs. The company focuses on developing novel medicines for treating cancers, autoimmune diseases, and other severe conditions. Key products include the PI3K/HDAC dual inhibitor BEBT-908 and multiple drugs in clinical trial phases targeting cancers. It's a United States subsidiary BeBetter Pharma specializes in next-generation siRNA therapeutics using proprietary delivery platforms aimed at complex diseases like kidney disorders, metabolic and liver diseases, and neurodegenerative conditions. Its pipeline includes oral and injectable drug candidates, some in late-stage trials, and aims to address unmet medical needs through novel mechanisms.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 397.2 | |||||
Equity-to-Asset | 0.97 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 10.1 | |||||
3-Year EPS without NRI Growth Rate | 4 | |||||
3-Year FCF Growth Rate | 14.4 | |||||
3-Year Book Growth Rate | 41.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 19.47 | |||||
9-Day RSI | 30.77 | |||||
14-Day RSI | 36.73 | |||||
3-1 Month Momentum % | -10.85 | |||||
6-1 Month Momentum % | -38.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 31.91 | |||||
Quick Ratio | 31.9 | |||||
Cash Ratio | 30.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.7 | |||||
Shareholder Yield % | 0.01 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -18.19 | |||||
ROA % | -17.4 | |||||
ROIC % | -175.53 | |||||
3-Year ROIIC % | 146.29 | |||||
ROC (Joel Greenblatt) % | -363.08 | |||||
ROCE % | -18.14 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 6.41 | |||||
Price-to-Tangible-Book | 6.57 | |||||
EV-to-EBIT | -60.24 | |||||
EV-to-EBITDA | -60.24 | |||||
EV-to-FCF | -66.56 | |||||
| Price-to-Net-Current-Asset-Value | 6.84 | |||||
| Price-to-Net-Cash | 7.09 | |||||
Earnings Yield (Greenblatt) % | -1.66 | |||||
FCF Yield % | -1.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BeBetter Med Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | |||
| EPS (TTM) (Â¥) | -0.426 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 36.73 | ||
| 14-Day ATR (Â¥) | 2.7053 | ||
| 20-Day SMA (Â¥) | 33.5545 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (Â¥) | 22.43 - 57.47 | ||
| Shares Outstanding (Mil) | 450.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BeBetter Med Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BeBetter Med Inc Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
BeBetter Med Inc Frequently Asked Questions
What is BeBetter Med Inc(SHSE:688759)'s stock price today?
The current price of SHSE:688759 is ¥23.20. The 52 week high of SHSE:688759 is ¥57.47 and 52 week low is ¥22.43.
When is next earnings date of BeBetter Med Inc(SHSE:688759)?
The next earnings date of BeBetter Med Inc(SHSE:688759) is .
Does BeBetter Med Inc(SHSE:688759) pay dividends? If so, how much?
BeBetter Med Inc(SHSE:688759) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BeBetter Med Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers